PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease

被引:320
作者
Baruch, Kuti [1 ]
Deczkowska, Aleksandra [1 ]
Rosenzweig, Neta [1 ]
Tsitsou-Kampeli, Afroditi [1 ]
Sharif, Alaa Mohammad [1 ]
Matcovitch-Natan, Orit [1 ,2 ]
Kertser, Alexander [1 ]
David, Eyal [2 ]
Amit, Ido [2 ]
Schwartz, Michal [1 ]
机构
[1] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel
[2] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
基金
欧洲研究理事会;
关键词
CHOROID-PLEXUS; NEURODEGENERATION; RECRUITMENT; MACROPHAGES; ACTIVATION;
D O I
10.1038/nm.4022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Systemic immune suppression may curtail the ability to mount the protective, cell-mediated immune responses that are needed for brain repair. By using mouse models of Alzheimer's disease (AD), we show that immune checkpoint blockade directed against the programmed death-1 (PD-1) pathway evokes an interferon (IFN)-gamma-dependent systemic immune response, which is followed by the recruitment of monocyte-derived macrophages to the brain. When induced in mice with established pathology, this immunological response leads to clearance of cerebral amyloid-beta (A beta) plaques and improved cognitive performance. Repeated treatment sessions were required to maintain a long-lasting beneficial effect on disease pathology. These findings suggest that immune checkpoints may be targeted therapeutically in AD.
引用
收藏
页码:135 / 137
页数:3
相关论文
共 20 条
[1]   Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology [J].
Arvanitakis, Z. ;
Grodstein, F. ;
Bienias, J. L. ;
Schneider, J. A. ;
Wilson, R. S. ;
Kelly, J. F. ;
Evans, D. A. ;
Bennett, D. A. .
NEUROLOGY, 2008, 70 (23) :2219-2225
[2]   Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer's disease pathology [J].
Baruch, Kuti ;
Rosenzweig, Neta ;
Kertser, Alexander ;
Deczkowska, Aleksandra ;
Sharif, Alaa Mohammad ;
Spinrad, Amit ;
Tsitsou-Kampeli, Afroditi ;
Sarel, Ayelet ;
Cahalon, Liora ;
Schwartz, Michal .
NATURE COMMUNICATIONS, 2015, 6
[3]   Aging-induced type I interferon response at the choroid plexus negatively affects brain function [J].
Baruch, Kuti ;
Deczkowska, Aleksandra ;
David, Eyal ;
Castellano, Joseph M. ;
Miller, Omer ;
Kertser, Alexander ;
Berkutzki, Tamara ;
Barnett-Itzhaki, Zohar ;
Bezalel, Dana ;
Wyss-Coray, Tony ;
Amit, Ido ;
Schwartz, Michal .
SCIENCE, 2014, 346 (6205) :89-93
[4]   New immunotherapies targeting the PD-1 pathway [J].
Chinai, Jordan M. ;
Janakiram, Murali ;
Chen, Fuxiang ;
Chen, Wantao ;
Kaplan, Mark ;
Zang, Xingxing .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (09) :587-595
[5]  
ElKhoury J, 1996, NATURE, V382, P716
[6]   Macrophages in Alzheimer's disease: the blood-borne identity [J].
Gate, David ;
Rezai-Zadeh, Kavon ;
Jodry, Dominique ;
Rentsendorj, Altan ;
Town, Terrence .
JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (08) :961-970
[7]   Innate immune activation in neurodegenerative disease [J].
Heneka, Michael T. ;
Kummer, Markus P. ;
Latz, Eicke .
NATURE REVIEWS IMMUNOLOGY, 2014, 14 (07) :463-477
[8]   Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase [J].
Jankowsky, JL ;
Fadale, DJ ;
Anderson, J ;
Xu, GM ;
Gonzales, V ;
Jenkins, NA ;
Copeland, NG ;
Lee, MK ;
Younkin, LH ;
Wagner, SL ;
Younkin, SG ;
Borchelt, DR .
HUMAN MOLECULAR GENETICS, 2004, 13 (02) :159-170
[9]   Opportunistic autoimmune disorcers potentiated by immune-checkpoint inhibitors anti-CTLA-4 and anti-PD-1 [J].
Kong, Yi-chi M. ;
Flynn, Jeffrey C. .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[10]   IFN-γ-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair [J].
Kunis, Gilad ;
Baruch, Kuti ;
Rosenzweig, Neta ;
Kertser, Alexander ;
Miller, Omer ;
Berkutzki, Tamara ;
Schwartz, Michal .
BRAIN, 2013, 136 :3427-3440